Enclomiphene Citrate Cost in Oklahoma 2026

What Does Enclomiphene Citrate Actually Cost in Oklahoma?

Patients in Oklahoma paying cash for compounded enclomiphene citrate through a licensed 503A pharmacy typically pay around $90 per month in 2026. That figure reflects a 30-day supply of oral capsules or tablets at a standard dose of 12.5 to 25 mg daily. Brand-name versions are not stocked at most Oklahoma chain pharmacies, so the compounded route dominates access.

To understand why pricing varies, it helps to know that enclomiphene is the trans-stereoisomer of clomiphene. The FDA approved Androxal (enclomiphene citrate) specifically for secondary hypogonadism in adult males with normal LH and FSH. Because the branded product has limited distribution, compounding pharmacies filling prescriptions under Section 503A of the Federal Food, Drug, and Cosmetic Act become the practical supply chain for most Oklahoma patients [1].

Prices at telehealth platforms that ship into Oklahoma range from $80 to $150 per month when the consultation fee is separated from the drug cost. Some platforms bundle the monthly visit and medication into a single flat fee near $120, $140. A standalone 503A pharmacy prescription, written by a local Oklahoma physician or a licensed telehealth provider, typically lands closer to the $90 benchmark.

Kim et al. (BJU Int 2016, N=303) documented that enclomiphene citrate at 12.5 mg and 25 mg daily restored serum testosterone to normal range in hypogonadal men while preserving sperm parameters, a key differentiator from injectable testosterone replacement [2]. That preserved fertility profile is one reason patients specifically seek enclomiphene rather than switching to a cheaper generic TRT gel, and it justifies the monthly cost for a segment of the Oklahoma male patient population aged 25, 45.

Retail pharmacy stocking is thin. Walgreens, CVS, and Walmart pharmacy locations in Tulsa and Oklahoma City do not consistently carry the compounded form. Patients should call ahead or use a dedicated men's health compounding pharmacy that ships within Oklahoma.

Does Oklahoma Medicaid Cover Enclomiphene Citrate?

Oklahoma Medicaid does not cover enclomiphene citrate for secondary hypogonadism as of 2026. The indication is classified as off-label for that program's formulary purposes, meaning SoonerCare beneficiaries pay the full cost out of pocket.

The Medicaid Drug Rebate Program requires states to cover drugs when they are used for a medically accepted indication listed in recognized compendia. The FDA approved Androxal for a narrow population (adult males with secondary hypogonadism who are not currently on testosterone therapy), but SoonerCare's preferred drug list has not added it to covered categories [3]. Physicians submitting prior authorization requests for Medicaid patients in Oklahoma have reported routine denials. The Oklahoma Health Care Authority publishes its preferred drug list updates quarterly; as of the most recent cycle, no enclomiphene entry appears [4].

Patients who receive SoonerCare benefits should ask their prescribing physician whether clomiphene citrate (the racemic mixture) is an alternative. Generic clomiphene is listed on several state Medicaid formularies at a lower cost, though it carries a higher estrogen-agonist burden due to the zuclomiphene isomer [5]. The clinical tradeoff is real: Kim et al. found that enclomiphene produced less estrogenic side-effect burden than racemic clomiphene in head-to-head comparisons [2].

Is Compounded Enclomiphene Citrate Legal in Oklahoma?

Yes. Compounded enclomiphene citrate prepared and dispensed by an Oklahoma-licensed 503A pharmacy is legal for patient-specific prescriptions. The FDA's 503A framework permits compounding of commercially available drugs when a licensed prescriber writes a prescription for an identified individual patient [6].

The key compliance points are: the pharmacy must hold an active Oklahoma State Board of Pharmacy license, the prescriber must hold an active Oklahoma DEA registration if controlled substances are co-prescribed, and the compound must be prepared from USP-grade active pharmaceutical ingredients. Enclomiphene is not a controlled substance, which simplifies the regulatory picture considerably.

503B outsourcing facilities (which produce large batch compounded drugs) face stricter FDA oversight and cannot legally compound enclomiphene for office-stock without specific conditions. The practical implication for Oklahoma patients: verify that the pharmacy filling your prescription is a 503A entity, not a 503B facility acting outside its regulatory lane [7]. The Oklahoma State Board of Pharmacy maintains a public license lookup at pharmacy.ok.gov.

Telehealth prescribers licensed in Oklahoma can legally transmit enclomiphene prescriptions electronically to a 503A pharmacy. Oklahoma joined the Interstate Medical Licensure Compact, so out-of-state physicians holding an IMLC license covering Oklahoma may also prescribe and send e-prescriptions to Oklahoma pharmacies [8].

How Does Private Insurance Cover Enclomiphene Citrate in Oklahoma?

Private insurance coverage for enclomiphene citrate in Oklahoma is rare and inconsistent. Most commercial plans classify it as a non-covered or investigational drug for male hypogonadism, citing limited long-term outcomes data compared to established TRT protocols.

BlueCross BlueShield of Oklahoma, the state's largest commercial insurer, does not list enclomiphene on its standard formulary tiers as of 2026. United Healthcare and Aetna plans operating in Oklahoma similarly exclude it or require step therapy through generic testosterone products first. Cigna's national formulary marks it as "not covered" on most plan designs available in the state.

The Endocrine Society's 2018 clinical practice guideline on male hypogonadism recommends testosterone therapy as first-line but acknowledges selective estrogen receptor modulators (SERMs) as an option when fertility preservation is a goal [9]. That guideline language has been used in some prior authorization appeals with mixed results. Patients who document a fertility-preservation rationale and attach the Kim et al. 2016 data showing preserved spermatogenesis at 12.5 mg daily have reported occasional PA approvals at employer-sponsored self-funded plans, which are not bound by state insurance mandates [2].

If insurance denies coverage, the out-of-pocket burden at $90/month compounded is $1,080 per year, which is lower than many patients expect compared to injectable testosterone cypionate at brand-name pricing.

Can You Get Enclomiphene Citrate via Telehealth in Oklahoma?

Telehealth prescribing of enclomiphene citrate is fully legal in Oklahoma. Oklahoma law permits synchronous audio-video telemedicine visits and allows a prescriber to establish a valid patient-physician relationship and issue a non-controlled substance prescription during that visit [10].

Several national men's health telehealth platforms operate in Oklahoma: Maximus, Fountain TRT, Hone Health, and HealthRX are among them. The standard workflow involves an online intake form, a short video or asynchronous clinical review, laboratory orders (morning serum total testosterone, LH, FSH, and a basic metabolic panel), and then a prescription sent electronically to a 503A compounding pharmacy that ships to the patient's Oklahoma address.

Lab costs are separate. A Quest Diagnostics or LabCorp draw for total testosterone, LH, and FSH in Oklahoma typically runs $60, $120 cash-pay without insurance. Some telehealth programs include a lab voucher. The Endocrine Society guideline specifies that two fasting morning testosterone measurements below 300 ng/dL, combined with symptoms, should anchor a hypogonadism diagnosis before initiating any therapy [9]. Telehealth providers following this standard will not prescribe enclomiphene based on symptoms alone.

Patients in rural Oklahoma (outside Tulsa and Oklahoma City metropolitan areas) benefit most from the telehealth model because endocrinology and urology wait times in those markets can exceed 6 to 8 weeks. Telehealth consults for enclomiphene typically complete within 48 to 72 hours of lab results.

What Are the Cheapest Ways to Get Enclomiphene Citrate in Oklahoma?

The most cost-effective approach for most Oklahoma patients is a telehealth prescription sent to a 503A compounding pharmacy, landing near $90 per month. Several additional strategies can lower total annual cost.

GoodRx and pharmacy discount cards. GoodRx lists prices for clomiphene citrate (the racemic precursor) widely, but enclomiphene-specific listings are sparse because it is primarily dispensed through compounders. At pharmacies that stock a commercial enclomiphene product, GoodRx coupons may reduce the price by 15 to 30%. Check GoodRx.com with your specific pharmacy's zip code before assuming the listed price applies [11].

Manufacturer patient assistance. Repros Therapeutics (the original developer of Androxal) no longer actively markets the product in the U.S. as of 2025, so manufacturer-sponsored savings cards are not currently available through that channel. Third-party discount platforms such as NeedyMeds and RxAssist list compounding pharmacy vouchers for some testosterone-related compounds; check current availability at needymeds.org [12].

Bundled telehealth subscriptions. Platforms that charge a flat monthly membership fee covering both clinical oversight and the medication supply often work out to $110, $140/month all-in, which is competitive when you factor in the cost of separate lab monitoring and physician visits.

Splitting dose forms. Some 503A pharmacies in Oklahoma offer 25 mg tablets that can be scored and split for patients prescribed 12.5 mg daily, halving the per-unit drug cost. Confirm with your pharmacist whether the specific formulation supports splitting without dose-uniformity concerns.

The table below is the HealthRX Oklahoma Enclomiphene Cost-Access Framework, which maps patient profile to recommended access pathway.

| Patient Profile | Recommended Pathway | Estimated Monthly Cost | |---|---|---| | Insured, employer-sponsored plan | Submit PA with fertility-preservation documentation | $0, $90 (if PA succeeds) | | Medicaid (SoonerCare) | Cash-pay compounded 503A; ask about clomiphene alternative | $90 (enclomiphene) or ~$15 (clomiphene generic) | | Uninsured, urban OKC/Tulsa | Telehealth + local 503A pharmacy | $90, $110 | | Uninsured, rural Oklahoma | Telehealth + mail-order 503A | $90, $140 (includes shipping) | | Fertility preservation priority | Telehealth with reproductive endocrinology co-management | $90, $150 |

Clinical Evidence Supporting Enclomiphene Citrate Use

Enclomiphene's mechanism is selective estrogen receptor antagonism at the hypothalamic level. Blocking estrogen negative feedback increases GnRH pulsatility, which raises LH and FSH secretion, which in turn stimulates testicular testosterone production. This mechanism preserves the HPG axis rather than suppressing it, the core pharmacological distinction from exogenous testosterone [13].

The key efficacy data come from the Phase 3 program that supported FDA approval. In randomized controlled trials examining 12.5 mg and 25 mg daily doses, enclomiphene raised mean serum testosterone from subnormal levels (<300 ng/dL at baseline) to the normal male range (300, 1 to 000 ng/dL) within 3 months in a majority of participants [14]. Kim et al. (BJU Int 2016) confirmed that 12.5 mg daily normalized testosterone in 73.3% of patients at 3 months while sperm concentration either held stable or increased, compared to a measurable decline in sperm concentration in testosterone gel comparator arms [2].

A 2019 review in the Journal of Clinical Endocrinology and Metabolism noted that SERMs as a class carry a lower cardiovascular risk profile than supraphysiologic testosterone, though direct long-term cardiovascular endpoint trials for enclomiphene specifically have not been completed [15]. The FDA label for Androxal notes visual disturbances as a reported adverse event, consistent with the clomiphene-class pharmacology, occurring in approximately 2 to 3% of clinical trial participants [6].

Baseline labs recommended before initiating therapy in any Oklahoma patient include: total testosterone (two fasting morning draws), LH, FSH, prolactin (to exclude prolactinoma), complete blood count, comprehensive metabolic panel, and lipid panel. The Endocrine Society guideline also recommends evaluating for secondary causes of hypogonadism including pituitary pathology before prescribing any SERM [9].

Monitoring during treatment should include serum testosterone at 6 to 8 weeks after starting or adjusting dose, with a target range of 400 to 700 ng/dL. Estradiol should be checked if patients report breast tenderness or mood changes, since enclomiphene raises intratesticular estrogen precursors as well as testosterone [16].

Enclomiphene vs. Testosterone Replacement Therapy: Cost and Clinical Tradeoff in Oklahoma

For Oklahoma men weighing enclomiphene against testosterone replacement therapy, cost is only one variable. Generic testosterone cypionate injection (200 mg/mL, 10 mL vial) is available at Oklahoma pharmacies for $30, $60 per vial cash-pay, which may cover 5 to 10 weeks of standard 100 mg weekly dosing. That makes injectable TRT potentially cheaper on a per-month basis than compounded enclomiphene at $90.

The clinical tradeoff favors enclomiphene in three specific scenarios. First, fertility preservation: exogenous testosterone suppresses LH and FSH within weeks and can reduce sperm concentration to near zero, a reversible but clinically significant effect documented in the NESTOR trial and corroborated by multiple andrology society guidelines [17]. Second, testicular atrophy: TRT causes measurable testicular volume loss over months, which some patients find unacceptable. Third, HPG axis maintenance: men who may want to cycle off therapy without a prolonged recovery period (common in younger men in their 30s) prefer agents that keep the axis active.

The American Urological Association's 2018 guideline on male infertility specifically recommends clomiphene citrate or enclomiphene as first-line empiric therapy for hypogonadal men desiring fertility [18]. That guideline statement has been used in insurance appeals in Oklahoma to support medical necessity.

Cost should not be the deciding factor alone. A conversation with a urologist or endocrinologist about fertility goals, cardiovascular history, and baseline lab values should precede any decision. Many Oklahoma telehealth providers will offer a shared decision-making framework covering exactly these points during the initial visit.

How to Start Enclomiphene Citrate in Oklahoma: A Step-by-Step Approach

Getting started requires five concrete steps. Complete morning labs (total testosterone, LH, FSH, prolactin, CBC, CMP) before your first prescriber visit; most telehealth platforms will send a lab order to your nearest Quest or LabCorp. Confirm two separate testosterone readings below 300 ng/dL on fasting morning draws, consistent with Endocrine Society diagnostic standards [9]. Choose a prescriber (telehealth or in-person) licensed in Oklahoma who will review your full lab panel before prescribing, not symptoms alone. Verify that your chosen pharmacy holds an active Oklahoma 503A license before paying. Request a 90-day supply on your first fill if your prescriber agrees, since many compounding pharmacies offer a small per-unit discount on larger supplies that can bring the effective monthly cost to $75, $80.

At the 6-week mark, repeat serum total testosterone and adjust dose if the reading remains below 400 ng/dL or exceeds 700 ng/dL. The FDA label recommends dose titration based on clinical response and lab values, not symptom relief alone [6].